AUPH - Aurinia Pharmaceuticals Inc. (AUPH) Q4 2023 Earnings Call Transcript
2024-02-15 10:10:28 ET
Aurinia Pharmaceuticals Inc. (AUPH)
Q4 2023 Earnings Conference Call
February 15, 2024 08:30 AM ET
Company Participants
Andrea Christopher - Head, Corporate Communications & Investor Relations
Peter Greenleaf - Chief Executive Officer
Joe Miller - Chief Financial Officer
Conference Call Participants
Farzin Haque - Jefferies
Stacy Ku - TD Cowen
Ed Arce - HC Wainwright
Presentation
Operator
Greetings. Welcome to Aurinia Pharmaceuticals' Full Year 2023 Earnings Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded.
I would now like to turn the conference over to your host, Andrea Christopher, Head of Corporate Communications and Investor Relations for Aurinia Pharmaceuticals. Thank you. You may begin.
Andrea Christopher
Thank you, operator and thank you to everyone for joining today’s call and webcast. Joining me on the call this morning are Peter Greenleaf, Aurinia's Chief Executive Officer; and Joe Miller, our Chief Financial Officer.
Today we will review and discuss Aurinia's 2023 fourth quarter and year-end financial and operational results as well as an update on our strategic review as communicated in the company's press release issued this morning.
The company also filed its annual financial statements on Form 10-K this morning. For more information, please refer to Aurinia's filings with the US Securities and Exchange Commission and applicable Canadian Securities authorities, which are also available on Aurinia's website at auriniapharma.com.
During today's call, Aurinia may make forward-looking statements based on current expectations. These forward-looking statements are subject to a number of significant risks and uncertainties and actual results may differ materially....
Aurinia Pharmaceuticals Inc. (AUPH) Q4 2023 Earnings Call Transcript